– Eton expects to significantly expand patient access to this critical treatment for Wilson disease patients –– $0 co-pay for all eligible patients and best-in-class patient support services –– Now ...
DEER PARK, Ill., March 03, 2025 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results